Real World Evidence Lead Endo-Metabolic, Global Rare Diseases

ppIn this role you drive the global Real World Evidence (RWE) strategy for the Endo-Met portfolio, aligning evidence plans with research and commercial goals. You lead cross-functional execution, shaping partnerships and data sourcing to inform regulatory, payer, and clinical decisions. You’ll advance innovative methodologies and publish impactful insights while building RWE capabilities across regions. This is a chance to influence asset strategy and contribute to transformative healthcare in rare diseases. /p ul lipension /li liprivate medical insurance /li lirelocation support /li liremote work options /li liLead the global RWE strategy for the Endo-Met GRD portfolio and ensure integration into regulatory, payer, and clinical decision-making /li liIncrease integration of real-world data sources to strengthen evidence-based decision making across development, regulatory, and commercialization phases /li liDevelop and maintain the integrated evidence generation plan (IEGP) in collaboration with cross-functional partners /li liBuild and scale RWE capabilities, processes, and infrastructure to support global and local evidence generation /li liIdentify, evaluate, and execute external RWD partnerships and data acquisition strategies, including due diligence and governance /li liProvide senior scientific leadership in observational research, epidemiology, and RWE methodologies /li liChampion adoption of AI/ML and advanced analytics in RWE generation /li liOversee governance of studies, registries, and non-interventional programs ensuring alignment with strategic priorities /li liRepresent Chiesi externally in scientific forums and drive publication strategy for RWE insights /li liLead cross-functional teams in a matrix environment, managing budgets, timelines, and resources with mentorship of junior staff /li liAdvanced degree (PhD, DrPH, MD, PharmD, MSc) in epidemiology, public health, health economics, or related field /li li8+ years of experience in RWE, HEOR, epidemiology, or observational research in pharma/biotech or related setting /li liProven success in leading RWE strategy at asset or portfolio level /li liStrong experience with real-world data sources (claims, EHR, registries, etc.) /li liTrack record of building partnerships and influencing senior stakeholders /li liExperience supporting regulatory and/or market access use of RWE /li liDeep expertise in epidemiology and RWE methodologies /li liAbility to translate evidence into business and clinical impact /li liProven ability to influence senior stakeholders and cross-functional leadership /li liExperience with advanced analytics, AI/ML, and innovative RWE approaches /li liAbility to shape data strategy and infrastructure decisions /li liStrong governance and oversight of multi-country studies and programs /li liAbility to manage competing priorities and large-scale initiatives /li liLeadership and people management /li liCross-functional collaboration /li liStakeholder influence and negotiation /li liEpidemiology and RWE methodologies /li liAI/ML and advanced analytics in RWE /li /ul pReal World Evidence Lead Endo-Metabolic, Global Rare Diseases salerno, campania, it /p /p #J-18808-Ljbffr